Protara Therapeutics Inc
Protara Therapeutics Inc Stock, NASDAQ:TARA
Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in 2017 and is headquartered in New York, NY.